#COVIDLongGame

COVID-19: Playing the Long Game

As the COVID-19 pandemic first surged across the country and around the world – impacting the nation’s economy, society and healthcare industry like never before – biotechnology and pharmaceutical companies quickly mobilized to combat the virus. While the first wave of vaccines and treatments entered the clinic for testing, hope for a quick solution was sparked and expectations were high. But as the coronavirus mutates and evolves, initial immunity may wane and early approaches may become obsolete or less effective. Hope for a long-term solution therefore may lie in the second or third generation of COVID-19 vaccines and therapies that took extra time to consider long-term need. This panel will feature experts and researchers pioneering innovative initiatives with the long game in mind.

Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.

Emily Baumgaertner

Los Angeles Times

Mark de Groot

Pattern Pharma

Hans Keirstead

AIVITA Biomedical, Inc.

Tom Lane

University of California, Irvine

Details

Primary Entry:
Platinum Badge
Interactive Badge
Secondary Entry:
Music Badge
Film Badge
Format:

Panel

Type:

Session

Track:

A New Urgency

Level:

Advanced